Human Genome Epidemiology Literature Finder
|
Records 1 - 7 (of 7 Records) |
| Query Trace: Ovarian Neoplasms and SP1[original query] |
|---|
| Novel functional single nucleotide polymorphisms in the latent transforming growth factor-beta binding protein-1L promoter: effect on latent transforming growth factor-beta binding protein-1L expression level and possible prognostic significance in ovarian cancer. The Journal of molecular diagnostics : JMD 2006 Jul 8 (3): 342-50. Higashi Tomomi, Kyo Satoru, Inoue Masaki, Tanii Hideji, Saijoh Kiyofu |
| MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent. Breast cancer research and treatment 2008 Oct 111 (3): 497-504. Yarden Ronit I, Friedman Eitan, Metsuyanim Sally, Olender Tsviya, Ben-Asher Edna, Papa Moshe Z |
| MDM2SNP309 does not associate with elevated MDM2 protein expression or breast cancer risk. Oncology 2008 Jun 74 (1-2): 84-87. Krekac D, Brozkova K, Knoflickova D, Hrstka R, Muller P, Nenutil R, Vojtesek B |
| The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians. Cancer cell 2011 Feb 19 (2): 273-82. Knappskog Stian, Bjørnslett Merete, Myklebust Line M, Huijts Petra E A, Vreeswijk Maaike P, Edvardsen Hege, Guo Yongli, Zhang Xuemei, Yang Ming, Ylisaukko-Oja Sanna K, Alhopuro Pia, Arola Johanna, Tollenaar Rob A E M, van Asperen Christi J, Seynaeve Caroline, Staalesen Vidar, Chrisanthar Ranjan, Løkkevik Erik, Salvesen Helga B, Evans D Gareth, Newman William G, Lin Dongxin, Aaltonen Lauri A, Børresen-Dale Anne-Lise, Tell Grethe S, Stoltenberg Camilla, Romundstad Pål, Hveem Kristian, Lillehaug Johan R, Vatten Lars, Devilee Peter, Dørum Anne, Lønning Per |
| SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer. European journal of cancer (Oxford, England : 1990) 2011 Nov . Knappskog S, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Romundstad P, Hveem K, Vatten L, Salvesen HB, Lønning PE |
| Association of myeloperoxidase with ovarian cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jan 35 (1): 141-8. Castillo-Tong Dan Cacsire, Pils Dietmar, Heinze Georg, Braicu Ioana, Sehouli Jalid, Reinthaller Alexander, Schuster Eva, Wolf Andrea, Watrowski Rafal, Maki Richard A, Zeillinger Robert, Reynolds Wanda |
| Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer. Oncotarget 2016 Jan . French Juliet D, Johnatty Sharon E, Lu Yi, Beesley Jonathan, Gao Bo, Kalimutho Murugan, Henderson Michelle J, Russell Amanda J, Kar Siddhartha, Chen Xiaoqing, Hillman Kristine M, Kaufmann Susanne, Sivakumaran Haran, O'Reilly Martin, Wang Chen, Korbie Darren J, Study Group Australian Ovarian Cancer, Study Australian Cancer, Lambrechts Diether, Despierre Evelyn, Nieuwenhuysen Els Van, Lambrechts Sandrina, Vergote Ignace, Karlan Beth, Lester Jenny, Orsulic Sandra, Walsh Christine, Fasching Peter A, Beckmann Matthias W, Ekici Arif B, Hein Alexander, Matsuo Keitaro, Hosono Satoyo, Pisterer Jacobus, Hillemanns Peter, Nakanishi Toru, Yatabe Yasushi, Goodman Marc T, Lurie Galina, Matsuno Rayna K, Thompson Pamela J, Pejovic Tanja, Bean Yukie, Heitz Florian, Harter Philipp, du Bois Andreas, Schwaab Ira, Hogdall Estrid, Kjaer Susanne K, Jensen Allan, Hogdall Claus, Lundvall Lene, Engelholm Svend Aage, Brown Bob, Flanagan James M, Metcalf Michelle D, Siddiqui Nadeem, Sellers Thomas, Fridley Brooke, Cunningham Julie, Schildkraut Joellen M, Iversen Ed, Weber Rachel Palmieri, Brennan Donal, Berchuck Andrew, Pharoah Paul, Harnett Paul, Norris Murray D, Haber Michelle, Goode Ellen L, Lee Jason S, Khanna Kum Kum, Meyer Kerstin B, Chenevix-Trench Georgia, deFazio Anna, Edwards Stacey L, MacGregor Stuart, Association Consortium On Behalf Of The Ovarian Canc |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: